Accessibility Menu
 
Fisher & Paykel Healthcare logo

Fisher & Paykel Healthcare

(ASX) FPH

Current Price$29.63
Market Cap$17.35B
Since IPO (2001)+2,700%
5 Year-2%
1 Year-4%
1 Month-3%

Fisher & Paykel Healthcare Financials at a Glance

Market Cap

$17.35B

Revenue (TTM)

$4.26B

Net Income (TTM)

$766.98M

EPS (TTM)

$0.67

P/E Ratio

43.52

Dividend

$0.46

Beta (Volatility)

-0.05 (Low)

Price

$29.63

Volume

137,629

Open

$29.30

Previous Close

$29.82

Daily Range

$29.30 - $29.95

52-Week Range

$29.03 - $35.28

FPH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fisher & Paykel Healthcare

Industry

Healthcare Equipment and Supplies

Employees

7,535

CEO

Lewis George Gradon

Headquarters

Auckland, 2013, NZ

FPH Financials

Key Financial Metrics (TTM)

Gross Margin

64%

Operating Margin

27%

Net Income Margin

20%

Return on Equity

23%

Return on Capital

26%

Return on Assets

16%

Earnings Yield

2.30%

Dividend Yield

1.54%

Payout Ratio

57.35%

Stock Overview

Market Cap

$17.35B

Shares Outstanding

587.29M

Volume

137.63K

Avg. Volume

477.53K

Financials (TTM)

Gross Profit

$530.20M

Operating Income

$371.00M

EBITDA

$654.30M

Operating Cash Flow

$548.60M

Capital Expenditure

$103.00M

Free Cash Flow

$445.60M

Cash & ST Invst.

$264.50M

Total Debt

$153.30M

Fisher & Paykel Healthcare Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.09B

+35.9%

Gross Profit

$692.17M

+42.4%

Gross Margin

63.39%

N/A

Market Cap

$17.35B

N/A

Market Cap/Employee

$2.49M

N/A

Employees

6,978

N/A

Net Income

$211.28M

+96.9%

EBITDA

$361.26M

+82.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$150.57M

+168.7%

Accounts Receivable

$328.73M

+51.2%

Inventory

$334.18M

-0.5%

Long Term Debt

$62.09M

-79.3%

Short Term Debt

$84.91M

+262.8%

Return on Assets

15.97%

N/A

Return on Invested Capital

26.29%

N/A

Free Cash Flow

$192.24M

+279.0%

Operating Cash Flow

$243.82M

+55.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PME.AXPro Medicus Limited
$136.20+1.34%
SHL.AXSonic Healthcare Limited
$19.93+0.81%
COH.AXCochlear Limited
$97.46+3.68%
ANN.AXAnsell Limited
$26.32-0.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$12.91+0.04%
SOFISoFi Technologies
$16.10+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About FPH

What is the current price of Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare is trading at A$29.63 per share.

What is the 52-week range for Fisher & Paykel Healthcare?

Over the past 52 weeks, Fisher & Paykel Healthcare has traded between A$29.03 and A$35.28.

How much debt does Fisher & Paykel Healthcare have?

As of the most recent reporting period, Fisher & Paykel Healthcare reported total debt of $139.33M.

How much cash does Fisher & Paykel Healthcare have on hand?

Fisher & Paykel Healthcare reported $240.39M in cash and cash equivalents in its most recent financial results.

What is Fisher & Paykel Healthcare’s dividend yield?

Fisher & Paykel Healthcare currently has a dividend yield of 1.54%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.